Navigation Links
Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden
Date:4/1/2013

WINSTON-SALEM, N.C., April 1, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the acceptance of the Company's Clinical Trial Application (CTA) filed with the Medical Products Agency (MPA) in Sweden to initiate a Phase 1 clinical trial to evaluate the safety and delivery of its Neo-Kidney Augment™ product in up to five patients with advanced chronic kidney disease (CKD). 

"We are excited to have received MPA approval for the Neo-Kidney Augment Phase 1 trial in Sweden and expect to initiate the trial this quarter. We will use the data from this trial to establish safety and a delivery approach for our planned U.S. Phase 1 trial, which we expect to start in the fourth quarter of 2013. We are confident that the Neo-Kidney Augment can truly benefit CKD patients in need of transformative, life-changing technologies," said John L. Miclot , President and Chief Executive Officer of Tengion.

Tengion's Neo-Kidney Augment is intended to prevent or delay the need for dialysis or kidney transplant by catalyzing the regeneration of functional kidney tissue in CKD patients. The Phase 1 trial will involve delivery of an active regenerative dose of Neo-Kidney Augment in patients with CKD. The trial is expected to enroll up to 5 patients in 2013 and will follow each patient for up to 2 years.

This CTA acceptance follows Tengion's inspection by an Official Qualified Person for regulatory compliance with European Medicines Agency standards for clinical manufacturing, processes, management, and quality programs. Following the successful inspection, the Company was issued a Declaration of Compliance to enable clinical production of the Neo-Kidney Augment at its cGMP manufacturing facility located in Winston-Salem, North Carolina.

About the Neo-Kidney Augment
'/>"/>

SOURCE Tengion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tengion Reports Second Quarter 2012 Financial Results
2. Tengion to Present at the BIO CEO & Investor Conference
3. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
4. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
5. Nephros Receives 510(k) Clearance for Hemodiafiltration System
6. ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
7. BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
8. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
9. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
10. Alexza Receives Complete Response Letter for Adasuve™ NDA
11. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014   What:   ... present data from a Phase I clinical trial of ... stop Parkinson,s disease progression. The Michael J. Fox Foundation ... will discuss the impact of the results for patients ... July 31, 2014         ...
(Date:7/29/2014)... 29, 2014  Drug development for hepatitis C ... rates and the intense need for curative therapy ... is underway as the market moves away from ... easily-tolerated, interferon-free oral therapies. Logo ... mega blockbuster Sovaldi is the first of these ...
(Date:7/29/2014)... RESEARCH TRIANGLE PARK, N.C. , July 29, ... focused on cloud-based drug design and development, announced ... I grant from the National Science Foundation Small ... is valued at $150,000. Cloud ... accelerates the development process by implementing new, innovative ...
Breaking Medicine Technology:Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4Cloud Pharmaceuticals Receives Phase I NSF SBIR Grant Valued at $150,000 2
... (NASDAQ: SVA ), a leading provider of biopharmaceutical ... Lee as a director to the Board of the Company ... who resigned from the Board due to personal reasons. ... a leading growth capital fund focused on China and India. ...
... The Neuroblastoma and Medulloblastoma Translational Research Consortium ... genomic-based clinical trial to treat and study pediatric ... The 11-member NMTRC, housed at Van ... of pediatric cancer clinical trial sites that includes ...
Cached Medicine Technology:Sinovac Appoints Kenneth Lee to Board of Directors 2Consortium Opens Landmark Personalized Medicine Children's Cancer Trial 2
(Date:7/29/2014)... NJ (PRWEB) July 29, 2014 Helping ... is an immensely complex challenge that requires deep knowledge ... knowledge to improve therapeutic options and outcomes has been ... professor of biomedical engineering, since he joined the NJIT ... whose significance is underscored by substantial funding from sources ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 A new ... during the 2014 Society for Cardiovascular Angiography and Interventions ... released this week. The videos review the benefits of ... services for the cardiac catheterization laboratory from the perspective ... the first video, Jane Kiah, MS, RN, Director of ...
(Date:7/29/2014)... TUESDAY, July 29, 2014 (HealthDay News) -- Quitting smoking is ... review. Depression can make it more difficult to ... come with trying to quit cold turkey, scientists found. But ... people quit faster, they said. "The review should be ... Moullec, a postdoctoral researcher in the department of exercise science ...
(Date:7/29/2014)... (GSA) the nation,s largest interdisciplinary organization devoted ... J. Bowers, PhD, RN, FAAN, of the University of ... on Minority Issues in Gerontology Outstanding Mentorship Award. , ... who has exemplified outstanding commitment and dedication to mentoring ... award presentation will take place at GSA,s 67th Annual ...
(Date:7/29/2014)... drinkers are three times more likely to drink alcohol ... to other alcohol brands, providing new and compelling evidence ... drinking behavior. , This is the conclusion ... Marketing and Youth (CAMY) at the Johns Hopkins Bloomberg ... of Public Health that examined whether exposure to brand-specific ...
Breaking Medicine News(10 mins):Health News:Continuing the Quest for Better Stroke Therapies 2Health News:Continuing the Quest for Better Stroke Therapies 3Health News:Continuing the Quest for Better Stroke Therapies 4Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 3Health News: Extra Exercise Could Help Depressed Smokers Quit: Study 2Health News:Bowers to receive GSA's 2014 Minority Mentorship Award 2Health News:Brand-specific television alcohol ads predict brand consumption among underage youth 2
... 12, 2008 ... , WHO/ WHAT: "Iron Andy" Holder, an Ironman Arizona competitor who was ... this Sunday,s triathlon to encourage others who have chronic ... their condition and to live without limits., ...
... Up to Promote New Appliance Line,s European, Style and Ingenious Features ... ... YORK, April 3, 2008 Known and admired for her,multi-tasking talents as ... Ripa for the North America launch of its new,premium kitchen appliance line ...
... screening, recommended by the Centers for Disease Control, ... critical to preventing still births and serious birth ... study published in the April issue of the ... statistics, when used to determine screening rates, may ...
... gap between stated and unstated feelings about Clinton, ... people feel more "insecure" than they are typically willing,to ... Company. In,addition, the "confidence" voters express about the U.S. ... surface and therefore does not appear to be,very deep., ...
... April 3, 2008 /PRNewswire/ - The GLOBAL ... service for,business executives in pharmaceutical and life ... and other industries,launches a Virtual Tour of ... COUNCIL service by visiting, http://www3.best-in-class.com/gr148.htm or ...
... The International Neuroinformatics Coordinating Facility (INCF) announces further ... the Neuroscience Peer Review Consortium (NPRC) initiative. The ... have agreed to accept manuscript reviews from other ... research articles. Currently, 27 journals have joined the ...
Cached Medicine News:Health News:Ironman Competitor with Diabetes Encourages Others to Live Without Limits; Competes in Ironman Arizona in Tempe 2Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 2Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 3Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 4Health News:Prenatal syphilis screening rates: Are they being accurately reported? 2Health News:Voting for Clinton Evokes Deep-Seated Feelings of Insecurity 2Health News:Global Benchmarking Council Launches New Virtual Tour of Research & Networking Service 2Health News:Neuroscience Peer Review Consortium announces increased journal participation 2
High-quality eyecare from the preferred name in diagnostic instruments....
Our 2.5v Streak Retinoscope Sets feature instruments with bright light, reliable handles, and convenient cases....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Medicine Products: